banner-about.jpg

We combat life–threatening infectious diseases

About

AJK Biopharmaceutical was founded in 2018 with a mission to combat life–threatening infectious diseases. We are focused on the clinical development of novel anti-infective drugs with emphasis on developing broad-spectrum antimicrobial cyclic peptides with activity against multi-drug resistant bacteria, anti-fungal and antiviral peptides.

Our Mission

AJK Biopharmaceutical is committed to discovering and developing antimicrobial agents that are effective against several drug-resistant bacterial pathogens, thus providing health care practitioners with critical new approaches to infections disease therapy.

Leadership

kazeminy.jpg

Assad Kazeminy, PhD.

Chairman

Assad J. Kazeminy is founder and former CEO of Irvine Pharmaceutical Services Inc. (CRO) and Avrio Biopharmaceutical LLC (CMO). He has more than 30 years of research experience in Analytical Chemistry and Biochemistry. 

dindyal-mandal.jpg

Dindyal Mandal, PhD.

Senior Scientist

My research interest from the beginning was always mostly interdisciplinary nature. During my Ph.D I worked at the interface of microbiology and chemistry. After getting sound knowledge in chemistry, specially different analytical tools, I was interested to work on the application of chemistry to solve the biological problems. 

Screen Shot 2022-10-25 at 11.40.44 PM.png

Jeremy Middleton

CEO

Jeremy Middleton joined as Chief Executive Officer in October of 2022.  Jeremy brings more than 30 years of global experience in both large and entrepreneurial life sciences companies with deep expertise in corporate development, strategic planning, operations and public-private partnerships. 

sandeep.jpg

Sandeep Lohan, PhD.

Senior Scientist

I am working as Senior Research Scientist at Infextious Therapeutics. The research themes underpinning my interests are of a multidisciplinary nature and fall broadly under the umbrella of medicinal chemistry. My current research is focused on the development of cationic macrocyclic peptides as novel antimicrobial agents.

tiwari.jpg

Rakesh Kumar Tiwari, PhD.

Academic Collaborator of NIH Grant (Medicinal Chemist)

Dr. Rakesh Kumar Tiwari, an assistant professor at the Chapman University School of Pharmacy. He is working in the area of developing antimicrobial peptides (AMPs) to combat antimicrobial resistance. He is skilled in the area of developing peptide-based compounds to provide a solution to the biological problem.

Board of Directors

david.jpg

David Pruitt, Esq.

David Pruitt provides leadership on legal affairs, business development, risk management, and innovative finance initiative at AJK Biopharmaceutical. He advises the board of directors and CEO on governance and strategy, and he is responsible for structuring collaboration with industry and public sector partners.

kazeminy.jpg

Assad Kazeminy, PhD.

Assad J. Kazeminy is founder and former CEO of Irvine Pharmaceutical Services Inc. (CRO) and Avrio Biopharmaceutical LLC (CMO). He has more than 30 years of research experience in Analytical Chemistry and Biochemistry. 

feyzi-fatehi.jpg

Feyzi Fatehi, PhD.

Feyzi Fatehi is a technology visionary, inventor, innovator, and entrepreneur. He was the recipient of the 2019 CODiE Lifetime Achievement Award, an award previously bestowed on Steve Jobs, Steve Wozniak, Bill Gates, and Paul Allen, among others.

phil-brancazio.jpg

Phil Brancazio

Phillip J. Brancazio - Retired Senior Vice President and General Manager of Par Pharmaceutical, Irvine CA an Endo International Company. Mr. Brancazio has over 40 years of pharmaceutical and medical device industry experience. 

Scientific Advisors

parang.jpg

Keykavous Parang, PhD.

Dr. Keykavous Parang, associate dean of research, graduate studies, and global affairs and a full professor of Medicinal Chemistry and Pharmacology at the Chapman University School of Pharmacy in Irvine, California. He is also a member of the Chao Family Comprehensive Cancer Center at the University of California, Irvine.

dominique.jpg

Dominique Gouty, PhD.

Dr. Dominique Gouty brings over 25 years of business leadership experience in multi-national Pharmaceutical / Healthcare and Services industries, spanning, clinical operations, diagnostics, manufacturing of Biologics and Bioanalytical testing of Protein Drugs, Cell Therapies and Gene Therapies.

james-wade.jpg

James Wade, PhD.

James is a clinical and academic leader, as well as a clinician-scientist, an educator, a nationally recognized and excellent cancer and infectious diseases physician, with extensive clinical care, research and healthcare technology experience and a long history of clinical and academic success.

michael-ibba.jpg

Michael Ibba, PhD.

Dr. Michael Ibba is the dean of Schmid College of Science and Technology at Chapman University, and also maintains a research group at The Ohio State University where he is a professor of microbiology.

gery.jpg

Greg Weiss, PhD.

Gregory Weiss is a Professor of Chemical Biology and Faculty Innovation Fellow at the University of California, Irvine (UCI) in the Departments of Chemistry, Molecular Biology and Biochemistry, and Pharmaceutical Sciences. He earned a BS from UC Berkeley and a PhD from Harvard. 

michael.jpg

Michael Buchmeier, PhD.

I am virologist and immunologist and with a strong career focus on RNA Viruses. I will bring to the project more than 35 years of experience with the Coronaviruses including the feline, FIP Virus, Mouse hepatitis virus, and most recently SARS CoV.